Neuroprotective effects of trehalose and sodium butyrate on preformed fibrillar form of α-synuclein-induced rat model of Parkinson's disease

V Kakoty, S KC, SK Dubey, CH Yang… - ACS Chemical …, 2021 - ACS Publications
Therapeutic options for Parkinson's disease (PD) are limited to a symptomatic approach,
making it a global threat. Targeting aggregated alpha-synuclein (α-syn) clearance is a gold …
被引用次数：25 相关文章

Neuroprotective Effects of Trehalose and Sodium Butyrate on Preformed Fibrillar Form of α-Synuclein-Induced Rat Model of Parkinson's Disease.

V Kakoty, SK Dubey, CH Yang… - ACS Chemical …, 2021 - europepmc.org
Therapeutic options for Parkinson's disease (PD) are limited to a symptomatic approach,
making it a global threat. Targeting aggregated alpha-synuclein (α-syn) clearance is a gold …

Neuroprotective Effects of Trehalose and Sodium Butyrate on Preformed Fibrillar Form of α-Synuclein-Induced Rat Model of Parkinson's Disease

V Kakoty, KC Sarathlal, SK Dubey… - ACS Chemical …, 2021 - hub.tmu.edu.tw
Therapeutic options for Parkinson's disease (PD) are limited to a symptomatic approach,
making it a global threat. Targeting aggregated alpha-synuclein (α-syn) clearance is a gold …

Neuroprotective Effects of Trehalose and Sodium Butyrate on Preformed Fibrillar Form of α-Synuclein-Induced Rat Model of Parkinson's Disease

V Kakoty, KC Sarathlal, SK Dubey… - ACS chemical …, 2021 - pubmed.ncbi.nlm.nih.gov
Therapeutic options for Parkinson's disease (PD) are limited to a symptomatic approach,
making it a global threat. Targeting aggregated alpha-synuclein (α-syn) clearance is a gold …

Neuroprotective Effects of Trehalose and Sodium Butyrate on Preformed Fibrillar Form of α-Synuclein-Induced Rat Model of Parkinson's Disease

V Kakoty, KC Sarathlal, SK Dubey… - ACS Chemical …, 2021 - hub.tmu.edu.tw
摘要Therapeutic options for Parkinson's disease (PD) are limited to a symptomatic
approach, making it a global threat. Targeting aggregated alpha-synuclein (α-syn) clearance …